Gateway Investment Advisers LLC Sells 45,248 Shares of UnitedHealth Group Inc (NYSE:UNH)
Gateway Investment Advisers LLC trimmed its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 8.2% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 504,101 shares of the healthcare conglomerate’s stock after selling 45,248 shares during the quarter. UnitedHealth Group comprises about 1.1% of Gateway Investment Advisers LLC’s investment portfolio, making the stock its 17th largest holding. Gateway Investment Advisers LLC owned approximately 0.05% of UnitedHealth Group worth $123,006,000 at the end of the most recent quarter.
A number of other large investors have also added to or reduced their stakes in UNH. Norges Bank acquired a new stake in UnitedHealth Group during the fourth quarter worth about $2,343,175,000. Thoroughbred Financial Services LLC grew its stake in UnitedHealth Group by 25,321.4% during the second quarter. Thoroughbred Financial Services LLC now owns 1,922,872 shares of the healthcare conglomerate’s stock worth $192,287,000 after buying an additional 1,915,308 shares in the last quarter. FMR LLC grew its stake in UnitedHealth Group by 1.9% during the fourth quarter. FMR LLC now owns 64,480,003 shares of the healthcare conglomerate’s stock worth $16,063,258,000 after buying an additional 1,232,189 shares in the last quarter. Geode Capital Management LLC grew its stake in UnitedHealth Group by 9.1% during the fourth quarter. Geode Capital Management LLC now owns 11,593,401 shares of the healthcare conglomerate’s stock worth $2,882,988,000 after buying an additional 965,763 shares in the last quarter. Finally, American Century Companies Inc. grew its stake in UnitedHealth Group by 12.8% during the fourth quarter. American Century Companies Inc. now owns 5,678,706 shares of the healthcare conglomerate’s stock worth $1,414,679,000 after buying an additional 644,872 shares in the last quarter. 85.65% of the stock is currently owned by institutional investors and hedge funds.
A number of equities research analysts have recently weighed in on UNH shares. Raymond James restated a “buy” rating on shares of West Fraser Timber in a research note on Friday, July 19th. Cantor Fitzgerald set a $620.00 price target on shares of Intuitive Surgical and gave the company a “buy” rating in a research note on Friday, July 19th. Barclays set a $24.00 price target on shares of Tenet Healthcare and gave the company a “hold” rating in a research note on Wednesday, April 17th. Royal Bank of Canada set a $311.00 price target on shares of UnitedHealth Group and gave the company a “buy” rating in a research note on Friday, July 19th. Finally, Bank of America restated a “buy” rating and issued a C$10.00 price target on shares of Hexo in a research note on Wednesday, April 17th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and eighteen have given a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average price target of $295.06.
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 EPS for the quarter, topping the consensus estimate of $3.46 by $0.14. UnitedHealth Group had a net margin of 5.51% and a return on equity of 25.20%. The business had revenue of $60.60 billion for the quarter, compared to the consensus estimate of $60.59 billion. During the same period last year, the company earned $3.14 EPS. The firm’s revenue was up 8.0% compared to the same quarter last year. On average, analysts forecast that UnitedHealth Group Inc will post 14.82 earnings per share for the current year.
In other UnitedHealth Group news, Director William C. Ballard, Jr. sold 12,000 shares of the firm’s stock in a transaction that occurred on Tuesday, July 23rd. The shares were sold at an average price of $255.31, for a total transaction of $3,063,720.00. Following the completion of the transaction, the director now owns 61,309 shares in the company, valued at approximately $15,652,800.79. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO David S. Wichmann purchased 20,000 shares of the stock in a transaction on Friday, May 3rd. The shares were purchased at an average price of $231.79 per share, with a total value of $4,635,800.00. Following the acquisition, the chief executive officer now owns 904,367 shares in the company, valued at approximately $209,623,226.93. The disclosure for this purchase can be found here. Over the last quarter, insiders have sold 37,000 shares of company stock worth $9,158,720. 0.87% of the stock is owned by corporate insiders.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Story: How liquidity affects the bid-ask spread
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.